Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial Dysfunction.
暂无分享,去创建一个
Y. Li | Mingzhi Zhao | G. Nie | S. Tong | T. Kaitu'u-Lino | Qi Chen | Yao Wang | Harmeet Singh | T. Kaitu’u-Lino
[1] T. Nero,et al. Activity-Modulating Monoclonal Antibodies to the Human Serine Protease HtrA3 Provide Novel Insights into Regulating HtrA Proteolytic Activities , 2014, PloS one.
[2] D. Charnock-Jones,et al. Redefining preeclampsia using placenta-derived biomarkers. , 2013, Hypertension.
[3] Ying Li,et al. HtrA3 Is Downregulated in Cancer Cell Lines and Significantly Reduced in Primary Serous and Granulosa Cell Ovarian Tumors , 2013, Journal of Cancer.
[4] H. Kurahashi,et al. Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia. , 2012, Placenta.
[5] Y. Li,et al. HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening , 2012, PloS one.
[6] M. Cheong,et al. High-Temperature Requirement Protein A4 (HtrA4) Suppresses the Fusogenic Activity of Syncytin-1 and Promotes Trophoblast Invasion , 2012, Molecular and Cellular Biology.
[7] S. Tong,et al. MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin , 2012, PloS one.
[8] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[9] D. Schust,et al. Preeclampsia: multiple approaches for a multifactorial disease , 2012, Disease Models & Mechanisms.
[10] R. Levine,et al. Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease , 2011, Circulation.
[11] Y. Endo,et al. Decidual HtrA3 negatively regulates trophoblast invasion during human placentation. , 2011, Human reproduction.
[12] R. Huber,et al. HTRA proteases: regulated proteolysis in protein quality control , 2011, Nature Reviews Molecular Cell Biology.
[13] E. Wallace,et al. Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia. , 2010, The Journal of clinical endocrinology and metabolism.
[14] H. Kleinman,et al. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract , 2010, Nature Protocols.
[15] J. Chien,et al. High Temperature Requirement A3 (HtrA3) Promotes Etoposide- and Cisplatin-induced Cytotoxicity in Lung Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.
[16] R. Kalluri,et al. The biology of preeclampsia. , 2009, Kidney international.
[17] J. Chien,et al. HtrA serine proteases as potential therapeutic targets in cancer. , 2009, Current cancer drug targets.
[18] J. Chien,et al. Serine Protease HtrA1 Associates with Microtubules and Inhibits Cell Migration , 2009, Molecular and Cellular Biology.
[19] I. Sargent,et al. Placental stress and pre-eclampsia: a revised view. , 2009, Placenta.
[20] C. Hubel,et al. The two stage model of preeclampsia: variations on the theme. , 2009, Placenta.
[21] A. Rowan,et al. Emerging roles of serine proteinases in tissue turnover in arthritis. , 2008, Arthritis and rheumatism.
[22] T. Nikolskaya,et al. A comprehensive functional analysis of tissue specificity of human gene expression , 2008, BMC Biology.
[23] Y. Asmann,et al. Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion. , 2008, American journal of obstetrics and gynecology.
[24] H. Kurahashi,et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. , 2007, Placenta.
[25] T. Libermann,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.
[26] Y. Li,et al. Serine Peptidase HTRA3 Is Closely Associated with Human Placental Development and Is Elevated in Pregnancy Serum1 , 2006, Biology of reproduction.
[27] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[28] Alfonso Baldi,et al. Implications of the serine protease HtrA1 in amyloid precursor protein processing , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Lindheimer,et al. World Health Organization Systematic Review of Screening Tests for Preeclampsia , 2004, Obstetrics and gynecology.
[30] Asif Ahmed,et al. Elevated Placental Soluble Vascular Endothelial Growth Factor Receptor-1 Inhibits Angiogenesis in Preeclampsia , 2004, Circulation research.
[31] R. Romero,et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. , 2004, American journal of obstetrics and gynecology.
[32] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[33] A. Baldi,et al. Distribution of the Serine Protease HtrA1 in Normal Human Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] J. Gamble,et al. Supernatants from dengue virus type‐2 infected macrophages induce permeability changes in endothelial cell monolayers , 2003, Journal of medical virology.
[35] L. Salamonsen,et al. Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. , 2003, The Biochemical journal.
[36] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[37] C. Southan,et al. The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.
[38] D. Granger,et al. Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. , 2002, American journal of obstetrics and gynecology.
[39] J. Kooner,et al. Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.
[40] Jm Roberts,et al. Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.
[41] James J. Walker,et al. Pre-eclampsia , 2000, The Lancet.
[42] C. Southan,et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. , 2000, European journal of biochemistry.
[43] D Bilder,et al. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. , 2000, Science.
[44] C. Fusco,et al. Characterization of a Novel Human Serine Protease That Has Extensive Homology to Bacterial Heat Shock Endoprotease HtrA and Is Regulated by Kidney Ischemia* , 2000, The Journal of Biological Chemistry.
[45] D. Luk,et al. Human HtrA, an Evolutionarily Conserved Serine Protease Identified as a Differentially Expressed Gene Product in Osteoarthritic Cartilage* , 1998, The Journal of Biological Chemistry.
[46] M. O'Sullivan,et al. Endothelial cell monolayers as a model system to investigate dengue shock syndrome. , 1998, Journal of virological methods.
[47] M. Drab,et al. Endothelial-cell permeability and protein kinase C in pre-eclampsia , 1998, The Lancet.
[48] J. Zumbrunn,et al. Primary structure of a putative serine protease specific for IGF‐binding proteins , 1996, FEBS letters.
[49] M. Lampugnani,et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts , 1992, The Journal of cell biology.
[50] M. Brown,et al. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. , 1989, Clinical science.
[51] D. Powell,et al. Barrier function of epithelia. , 1981, The American journal of physiology.